Dr Andrew Barbour

Honorary Associate
NHMRC Clinical Trials Centre, Sydney Medical School

Telephone 07 32405309
Fax 07 32405390

Map

Selected grants

2012

  • CTC STA Aus Barbour; Barbour A; Specialised Therapeutics Australia Pty Ltd/Research Contract.
  • Personalising care in resectable pancreas cancer. GAP-T: a study of imaging and molecular biomarkers to guide treatment of patients receiving preoperative chemotherapy followed by surgery.; Barbour A, Goldstein D, Goldstein D, Kench J, Yip S, Mead S, Brown C, Chang D; National Health and Medical Research Council (NHMRC)/Project Grants.

2011

  • DOCetaxel with or without radiation Therapy for resectable Oesophageal adenocarcinoma based on early PET Response to induction chemotherapy (DOCTOR); Goldstein D, Brown C, Yip S, Barbour A; National Health and Medical Research Council (NHMRC)/Project Grants.

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Shah, A., Hartel, G., Brown, I., Winterford, C., Na, R., Le Cao, K., Spicer, B., Dunstone, M., Phillips, W., Barbour, A., et al (2018). Evaluation of serum glycoprotein biomarker candidates for detection of esophageal adenocarcinoma and surveillance of Barrett's esophagus. Molecular and Cellular Proteomics, 17(12), 2324-2334. [More Information]
  • Kroon, H., Coventry, B., Giles, M., Henderson, M., Speakman, D., Wall, M., Barbour, A., Serpell, J., Paddle, P., Smithers, B., Thompson, J. (2017). Safety and Efficacy of Isolated Limb Infusion Chemotherapy for Advanced Locoregional Melanoma in Elderly Patients: An Australian Multicenter Study. Annals of Surgical Oncology, 24(11), 3245-3251. [More Information]
  • Butler, N., Samra, J., Nikfarjam, M., Barbour, A. (2016). Pancreatic cancer: Is the surgeon still relevant? Cancer Forum, 40(1), 39-42.
  • Gandy, R., Barbour, A., Samra, J., Nikfarjam, M., Haghighi, K., Kench, J., Saxena, P., Goldstein, D. (2016). Refining the care of patients with pancreatic cancer: the AGITG Pancreatic Cancer Workshop consensus. Medical Journal of Australia, 204(11), 419-422. [More Information]
  • Chandrasegaram, M., Goldstein, D., Simes, R., Gebski, V., Kench, J., Gill, A., Samra, J., Merrett, N., Richardson, A., Barbour, A. (2015). Meta-analysis of radical resection rates and margin assessment in pancreatic cancer. British Journal of Surgery, 102(12), 1459-1472. [More Information]
  • Tembe, V., Schramm, S., Stark, M., Patrick, E., Jayaswal, V., Tang, Y., Barbour, A., Hayward, N., Thompson, J., Scolyer, R., Yang, J., Mann, G. (2015). microRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosis. Pigment Cell & Melanoma Research, 28(3), 254-226. [More Information]
  • Stark, M., Klein, K., Weide, B., Haydu, L., Pflugfelder, A., Tang, Y., Palmer, J., Whiteman, D., Scolyer, R., Mann, G., Thompson, J., Long, G., et al (2015). The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression Analysis. EBioMedicine, 2(7), 671-680. [More Information]
  • Liyanage, S., Segelov, E., Garland, S., Tabrizi, S., Seale, H., Crowe, P., Dwyer, D., Barbour, A., Newall, A., Malik, A., et al (2013). Role of human papillomaviruses in esophageal squamous cell carcinoma. Asia-Pacific Journal of Clinical Oncology, 9(1), 12-28. [More Information]
  • Cameron, A., Barbour, A., Wayte, N., Akhurst, T. (2011). Biomarkers in oesophagogastric cancers. Cancer Forum, 35(3), 160-166.

2018

  • Shah, A., Hartel, G., Brown, I., Winterford, C., Na, R., Le Cao, K., Spicer, B., Dunstone, M., Phillips, W., Barbour, A., et al (2018). Evaluation of serum glycoprotein biomarker candidates for detection of esophageal adenocarcinoma and surveillance of Barrett's esophagus. Molecular and Cellular Proteomics, 17(12), 2324-2334. [More Information]

2017

  • Kroon, H., Coventry, B., Giles, M., Henderson, M., Speakman, D., Wall, M., Barbour, A., Serpell, J., Paddle, P., Smithers, B., Thompson, J. (2017). Safety and Efficacy of Isolated Limb Infusion Chemotherapy for Advanced Locoregional Melanoma in Elderly Patients: An Australian Multicenter Study. Annals of Surgical Oncology, 24(11), 3245-3251. [More Information]

2016

  • Butler, N., Samra, J., Nikfarjam, M., Barbour, A. (2016). Pancreatic cancer: Is the surgeon still relevant? Cancer Forum, 40(1), 39-42.
  • Gandy, R., Barbour, A., Samra, J., Nikfarjam, M., Haghighi, K., Kench, J., Saxena, P., Goldstein, D. (2016). Refining the care of patients with pancreatic cancer: the AGITG Pancreatic Cancer Workshop consensus. Medical Journal of Australia, 204(11), 419-422. [More Information]

2015

  • Chandrasegaram, M., Goldstein, D., Simes, R., Gebski, V., Kench, J., Gill, A., Samra, J., Merrett, N., Richardson, A., Barbour, A. (2015). Meta-analysis of radical resection rates and margin assessment in pancreatic cancer. British Journal of Surgery, 102(12), 1459-1472. [More Information]
  • Tembe, V., Schramm, S., Stark, M., Patrick, E., Jayaswal, V., Tang, Y., Barbour, A., Hayward, N., Thompson, J., Scolyer, R., Yang, J., Mann, G. (2015). microRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosis. Pigment Cell & Melanoma Research, 28(3), 254-226. [More Information]
  • Stark, M., Klein, K., Weide, B., Haydu, L., Pflugfelder, A., Tang, Y., Palmer, J., Whiteman, D., Scolyer, R., Mann, G., Thompson, J., Long, G., et al (2015). The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression Analysis. EBioMedicine, 2(7), 671-680. [More Information]

2013

  • Liyanage, S., Segelov, E., Garland, S., Tabrizi, S., Seale, H., Crowe, P., Dwyer, D., Barbour, A., Newall, A., Malik, A., et al (2013). Role of human papillomaviruses in esophageal squamous cell carcinoma. Asia-Pacific Journal of Clinical Oncology, 9(1), 12-28. [More Information]

2011

  • Cameron, A., Barbour, A., Wayte, N., Akhurst, T. (2011). Biomarkers in oesophagogastric cancers. Cancer Forum, 35(3), 160-166.

To update your profile click here. For support on your academic profile contact .